No infectious SARS-CoV-2 in breast milk from a cohort of 110 lactating women
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Background
Genomic RNA of severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) has been detected in the breast milk of lactating women, but its pathological significance has remained uncertain due to the small size of prior studies.
Methods
Breast milk from 110 lactating women was analyzed by reverse transcription-polymerase chain reaction (285 samples) and viral culture (160 samples). Those containing SARS-CoV-2 viral RNA (vRNA) were examined for the presence of subgenomic RNA (sgRNA), a putative marker of infectivity.
Results
Sixty-five women had a positive SARS-CoV-2 diagnostic test, 9 had symptoms but negative diagnostic tests, and 36 symptomatic women were not tested. SARS-CoV-2 vRNA was detected in the milk of 7 (6%) women with either a confirmed infection or symptomatic illness, including 6 of 65 (9%) women with a positive SARS-CoV-2 diagnostic test. Infectious virus was not detected in any culture and none had detectable sgRNA. In control experiments, infectious SARS-CoV-2 could be cultured after addition to breastmilk despite several freeze–thaw cycles, as it occurs in the storage and usage of human milk.
Conclusions
SARS-CoV-2 RNA can be found infrequently in the breastmilk after recent infection, but we found no evidence that breastmilk contains an infectious virus or that breastfeeding represents a risk factor for transmission of infection to infants.
Impact
-
This article goes beyond prior small studies to provide evidence that infectious SARS-CoV-2 is not present in the milk of lactating women with recent infection, even when SARS-CoV-2 RNA is detected.
-
Recent SARS-CoV-2 infection or detection of its RNA in human milk is not a contraindication to breastfeeding.
Article activity feed
-
-
SciScore for 10.1101/2021.04.05.21254897: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Participants and Breast Milk Specimens: As previously described 9 breast milk samples and clinical information were obtained from women participating in the Mommy’s Milk Human Milk Biorepository at the University of California, San Diego (IRB#130658). Table 2: Resources
Software and Algorithms Sentences Resources SPSS version 25 was used for analyses, and Prism version 8.4.3 (GraphPad) was used for figure presentation. SPSSsuggested: (SPSS, RRID:SCR_002865)Prismsuggested: (PRISM, RRID:SCR_005375)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results…
SciScore for 10.1101/2021.04.05.21254897: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable Participants and Breast Milk Specimens: As previously described 9 breast milk samples and clinical information were obtained from women participating in the Mommy’s Milk Human Milk Biorepository at the University of California, San Diego (IRB#130658). Table 2: Resources
Software and Algorithms Sentences Resources SPSS version 25 was used for analyses, and Prism version 8.4.3 (GraphPad) was used for figure presentation. SPSSsuggested: (SPSS, RRID:SCR_002865)Prismsuggested: (PRISM, RRID:SCR_005375)GraphPadsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:This study is unprecedented in the use of viral cultures to examine a very large number of breast milk specimens, a limitation of prior studies cited by Lackey et al19. We found that SARS-CoV-2 RNA is seldom detected in breast milk samples from women with confirmed SARS-CoV-2 infection. Moreover, our longitudinal follow-up indicates that even when it is detected, it is an unlikely source of infection for the breastfed baby: viral RNA was only transiently present and we were unable to culture SARS-CoV-2 from any sample. This study had several limitations as well as strengths. The collection of breast milk samples was not directly observed and we relied on the maternal report of SARS-CoV-2 test results, symptoms and treatments received. However, all participants completed a semi-structured interview guided by trained study staff who prompted for specifics with the aid of a calendar. In addition, to our knowledge, this study represents the largest number of breast milk samples analyzed to date from SARS-CoV-2 infected women. We demonstrated that the SARS-CoV-2 maintains its infectivity despite repeated freezing and thawing and storage at 4°C. In addition, while sgRNA (a potential indicator of virus replication) was not detected in any of the milk specimens already known to contain SARS-CoV-2 RNA, this assay is only moderately sensitive: sgRNA is present in only about half of nasopharyngeal specimens with positive viral cultures (13,15and unpublished data by PK).
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a protocol registration statement.
-